Clinical Trials Browser

Solid Tumor

NCT06097728 2026-03-04

eVOLVE-Meso

Phase 3 Recruiting

825 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT05579366 2026-03-03

RAINFOL-01

Phase 1/2 Recruiting

764 enrolled

BreastGynecologicOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

eVOLVE-Meso

RAINFOL-01

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

KANDLELIT-001

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

RETINO 2018

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

PENINSULA

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma